539206 — Genomic Valley Biotech Balance Sheet

0.000.00%

Last trade - 00:00

IndustrialsSpeculativeMicro CapMomentum Trap

Annual balance sheet for Genomic Valley Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Preliminary
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	0.027	0.413	0.061	0.452	0.262
Net Total Accounts Receivable
Net Total Receivables	0	22.2	25.3	22.1	23.2
Total Inventory
Total Other Current Assets
Total Current Assets	11.4	25.8	29.1	26.2	27
Net Property, Plant And Equipment	17.5	0.032	0.021	0.087	0.05
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	38	44.2	43.3	43.6	42.5
Accounts Payable
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.14	8.93	7.91	4.58	3.21
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	9.19	8.94	7.92	4.58	3.21
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	28.8	35.3	35.4	39	39.3
Total Liabilities & Shareholders' Equity	38	44.2	43.3	43.6	42.5
Total Common Shares Outstanding